Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "Czech-Republic"

15 News Found

Lupin signs distribution agreement with Medis for Orphan Drug NaMuscla@
News | February 09, 2022

Lupin signs distribution agreement with Medis for Orphan Drug NaMuscla@

NDM disorders are a group of rare, inherited neuromuscular disorders which is characterized by the inability to relax muscles following voluntary contraction


Abbott announces world's first implant of dual-chamber leadless pacemaker in pivotal trial
Medical Device | February 08, 2022

Abbott announces world's first implant of dual-chamber leadless pacemaker in pivotal trial

Proprietary implant-to-implant (i2i) device technology is used for communication between two implanted leadless pacemakers to regulate the heart rate


Glenmark receives U.S. FDA approval for Ryaltris
Drug Approval | January 14, 2022

Glenmark receives U.S. FDA approval for Ryaltris

The recommended daily dose for Ryaltris is 2 sprays in each nostril twice daily


Glenmark receives marketing approval for Ryaltris in 13 countries across the EU and UK
Drug Approval | September 30, 2021

Glenmark receives marketing approval for Ryaltris in 13 countries across the EU and UK

Ryaltris is a fixed dose combination nasal spray that combines an antihistamine (Olopatadine) with a steroid (Mometasone Furoate) for treatment of allergic rhinitis


Glenmark’s Ryaltris nasal spray approved in Europe
News | April 27, 2021

Glenmark’s Ryaltris nasal spray approved in Europe

In some countries such as France, Italy, Spain and the Balkan region, Menarini Group will lead the commercialisation effort, as part of an exclusive licensing agreement signed with Glenmark